Combination Navitoclax, Venetoclax and Decitabine for Advanced Myeloid Neoplasms
Status:
Not yet recruiting
Trial end date:
2026-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to test the safety of a new three drug combination of
navitoclax, decitabine, and venetoclax to treat advanced myeloid malignancies.
The names of the drugs involved in this study are:
- Venetoclax
- Decitabine
- Navitoclax